An opportunity to focus not only on research, but the treatment options now available to women
Dr Nina Bailey | October 6, 2010 | 2 comments
The shocking truth about how pharmaceutical companies hired ghostwriters to distort results.
AnnA Rushton | October 5, 2010 | 8 comments
Dr Dach scrutinises the evidence on bio-identical hormones and their safety in the first of a 3 part series.
Dr Jeffrey Dach | September 10, 2010 | 3 comments
Dr Dach reveals how pharmaceutical companies are paying ghost writers to produce medical articles for publication that attempt to convince doctors to prescribe synthetic hormones instead of bioidenticals.
Dr Jeffrey Dach | August 25, 2010 | 4 comments
If you want to know more about the medical research into bioidentical hormones, then start here.
AnnA Rushton | May 18, 2010 | 0 comments
Dr Bond explains this common phenomenon, its causes and consequences.
Dame Dr Shirley Bond | March 29, 2010 | 15 comments
A study undertaken in 2009 at Stanford University in California found that women who take HRT for more than five years double their risk of suffering breast cancer for every 12 months they spend taking it.
AnnA Rushton | March 16, 2010 | 3 comments
The jury made this award on the basis that the company, Wyeth, failed to warn about the risks of the drug and took only minutes to come to their decision.
AnnA Rushton | March 16, 2010 | 5 comments
A Danish government report has confirmed that chemicals such as PVC, flame retardants, phthalates, dioxins, PCBs and bisphenol-A are probably continuing to contribute to the birth of fewer males and the feminization of existing ones.
AnnA Rushton | March 16, 2010 | 0 comments
On 15 March, 2010 Pfizer announced that they have stopped a phase-III trial of their monoclonal antibody Figitumumab and two trials of Sunitinib in breast cancer after they failed to show significant improvement in survival rates.
AnnA Rushton | March 15, 2010 | 0 comments